182 related articles for article (PubMed ID: 29367668)
1. Honokiol is a FOXM1 antagonist.
Halasi M; Hitchinson B; Shah BN; Váraljai R; Khan I; Benevolenskaya EV; Gaponenko V; Arbiser JL; Gartel AL
Cell Death Dis; 2018 Jan; 9(2):84. PubMed ID: 29367668
[TBL] [Abstract][Full Text] [Related]
2. A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS.
Halasi M; Váraljai R; Benevolenskaya E; Gartel AL
J Biol Chem; 2016 Jan; 291(1):142-8. PubMed ID: 26559972
[TBL] [Abstract][Full Text] [Related]
3. Oligochitosan-pluronic 127 conjugate for delivery of honokiol.
Song Z; Sun J; Deng P; Zhou F; Xu H; Wen Y; Teng F; Ge D; Feng R
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):740-750. PubMed ID: 29400085
[TBL] [Abstract][Full Text] [Related]
4. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
[TBL] [Abstract][Full Text] [Related]
6. Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.
Li HY; Ye HG; Chen CQ; Yin LH; Wu JB; He LC; Gao SM
J Cell Biochem; 2015 Feb; 116(2):287-98. PubMed ID: 25187418
[TBL] [Abstract][Full Text] [Related]
7. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
8. Honokiol and its analogues as anticancer compounds: Current mechanistic insights and structure-activity relationship.
Prasher P; Fatima R; Sharma M; Tynybekov B; Alshahrani AM; Ateşşahin DA; Sharifi-Rad J; Calina D
Chem Biol Interact; 2023 Dec; 386():110747. PubMed ID: 37816447
[TBL] [Abstract][Full Text] [Related]
9. The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways.
Banerjee P; Basu A; Arbiser JL; Pal S
Cancer Lett; 2013 Sep; 338(2):292-9. PubMed ID: 23752066
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
11. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
12. Semisynthesis and biological evaluation of novel honokiol thioethers against colon cancer cells HCT116 via inhibiting the transcription and expression of YAP protein.
Yang R; Fu X; Fan J; Wang T; Song J; Xu T; Guo Y; Zhang SY
Bioorg Med Chem; 2024 Jun; 107():117762. PubMed ID: 38759254
[TBL] [Abstract][Full Text] [Related]
13. Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK/IκB/NF-κB, in atherosclerotic cell model.
Qiu L; Xu R; Wang S; Li S; Sheng H; Wu J; Qu Y
Exp Mol Med; 2015 Jul; 47(7):e171. PubMed ID: 26138903
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM
Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
[TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits H(2)O(2)-induced apoptosis in human lens epithelial cells via inhibition of the mitogen-activated protein kinase and Akt pathways.
Tang X; Yao K; Zhang L; Yang Y; Yao H
Eur J Pharmacol; 2011 Jan; 650(1):72-8. PubMed ID: 20965163
[TBL] [Abstract][Full Text] [Related]
16. FoxM1 is a general target for proteasome inhibitors.
Bhat UG; Halasi M; Gartel AL
PLoS One; 2009 Aug; 4(8):e6593. PubMed ID: 19672316
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
18. In vitro growth inhibition of human cancer cells by novel honokiol analogs.
Lin JM; Prakasha Gowda AS; Sharma AK; Amin S
Bioorg Med Chem; 2012 May; 20(10):3202-11. PubMed ID: 22533983
[TBL] [Abstract][Full Text] [Related]
19. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
Lee B; Kim CH; Moon SK
FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
[TBL] [Abstract][Full Text] [Related]
20. Honokiol inhibits vascular vessel formation of mouse embryonic stem cell-derived endothelial cells via the suppression of PECAM and MAPK/mTOR signaling pathway.
Kim GD; Bae SY; Park HJ; Bae K; Lee SK
Cell Physiol Biochem; 2012; 30(3):758-70. PubMed ID: 22890153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
